tiprankstipranks
Trending News
More News >
Beauty Health (SKIN)
NASDAQ:SKIN
US Market
Advertisement

Beauty Health (SKIN) Stock Forecast & Price Target

Compare
283 Followers
See the Price Targets and Ratings of:

SKIN Analyst Ratings

Hold
5Ratings
Hold
0 Buy
5 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Beauty
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SKIN Stock 12 Month Forecast

Average Price Target

$2.00
▼(-3.38% Downside)
Based on 5 Wall Street analysts offering 12 month price targets for Beauty Health in the last 3 months. The average price target is $2.00 with a high forecast of $2.50 and a low forecast of $1.50. The average price target represents a -3.38% change from the last price of $2.07.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","3":"$3","4":"$4"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1,2,3,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.53,1.6046153846153846,1.6792307692307693,1.7538461538461538,1.8284615384615384,1.903076923076923,1.9776923076923076,2.0523076923076924,2.126923076923077,2.2015384615384614,2.2761538461538464,2.350769230769231,2.4253846153846155,{"y":2.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.53,1.5661538461538462,1.6023076923076924,1.6384615384615384,1.6746153846153846,1.7107692307692308,1.746923076923077,1.7830769230769232,1.8192307692307692,1.8553846153846154,1.8915384615384616,1.9276923076923076,1.9638461538461538,{"y":2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.53,1.5276923076923077,1.5253846153846153,1.523076923076923,1.5207692307692309,1.5184615384615385,1.5161538461538462,1.5138461538461538,1.5115384615384615,1.5092307692307692,1.506923076923077,1.5046153846153847,1.5023076923076923,{"y":1.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.6,"date":1709251200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.17,"date":1714521600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.7,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.66,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.52,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.59,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.23,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.03,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.6,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.16,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.53,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2.50Average Price Target$2.00Lowest Price Target$1.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on SKIN
TD Cowen
TD Cowen
$2
Hold
-3.38%
Downside
Reiterated
08/08/25
TD Cowen Keeps Their Hold Rating on Beauty Health (SKIN)We maintain our PT of $2 based on 1.5x FY2 EV/Sales.
Stifel Nicolaus Analyst forecast on SKIN
Stifel Nicolaus
Stifel Nicolaus
$2
Hold
-3.38%
Downside
Reiterated
08/08/25
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Post Holdings (NYSE: POST) and Beauty Health (NASDAQ: SKIN)
Benchmark Co. Analyst forecast on SKIN
Benchmark Co.
Benchmark Co.
Hold
Reiterated
08/08/25
Benchmark Co. Keeps Their Hold Rating on Beauty Health (SKIN)
Canaccord Genuity Analyst forecast on SKIN
Canaccord Genuity
Canaccord Genuity
$1.5
Hold
-27.54%
Downside
Reiterated
08/07/25
Cautious Hold Rating on Beauty Health Amid Economic Challenges and Strategic AdjustmentsWe are also seeing more machine placements with 957 new machine placements in the quarter, an acceleration from 583 in 1Q. However, churn rates also trended slightly higher in the quarter. The consumables business has held up, indicating consumers are still opting for the aesthetic treatment despite the volatile macro conditions. 2Q performance and recent trends led to management raising FY25 expectations despite increased investment plans and tariff pressures. Overall, we are becoming incrementally more positive as management has done a good job stabilizing the business. This should position the company well to drive strong growth once macro conditions improve. However, we remain on the sidelines as new machine placements will likely remain pressured in the near-term given the higher interest rate environment and uncertain macro conditions and reiterate our $1.50 PT.
Piper Sandler Analyst forecast on SKIN
Piper Sandler
Piper Sandler
$1
Sell
-51.69%
Downside
Reiterated
05/09/25
Beauty Health (SKIN) Receives a Sell from Piper Sandler
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on SKIN
TD Cowen
TD Cowen
$2
Hold
-3.38%
Downside
Reiterated
08/08/25
TD Cowen Keeps Their Hold Rating on Beauty Health (SKIN)We maintain our PT of $2 based on 1.5x FY2 EV/Sales.
Stifel Nicolaus Analyst forecast on SKIN
Stifel Nicolaus
Stifel Nicolaus
$2
Hold
-3.38%
Downside
Reiterated
08/08/25
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Post Holdings (NYSE: POST) and Beauty Health (NASDAQ: SKIN)
Benchmark Co. Analyst forecast on SKIN
Benchmark Co.
Benchmark Co.
Hold
Reiterated
08/08/25
Benchmark Co. Keeps Their Hold Rating on Beauty Health (SKIN)
Canaccord Genuity Analyst forecast on SKIN
Canaccord Genuity
Canaccord Genuity
$1.5
Hold
-27.54%
Downside
Reiterated
08/07/25
Cautious Hold Rating on Beauty Health Amid Economic Challenges and Strategic AdjustmentsWe are also seeing more machine placements with 957 new machine placements in the quarter, an acceleration from 583 in 1Q. However, churn rates also trended slightly higher in the quarter. The consumables business has held up, indicating consumers are still opting for the aesthetic treatment despite the volatile macro conditions. 2Q performance and recent trends led to management raising FY25 expectations despite increased investment plans and tariff pressures. Overall, we are becoming incrementally more positive as management has done a good job stabilizing the business. This should position the company well to drive strong growth once macro conditions improve. However, we remain on the sidelines as new machine placements will likely remain pressured in the near-term given the higher interest rate environment and uncertain macro conditions and reiterate our $1.50 PT.
Piper Sandler Analyst forecast on SKIN
Piper Sandler
Piper Sandler
$1
Sell
-51.69%
Downside
Reiterated
05/09/25
Beauty Health (SKIN) Receives a Sell from Piper Sandler
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Beauty Health

1 Month
xxx
Success Rate
12/19 ratings generated profit
63%
Average Return
+1.44%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.16% of your transactions generating a profit, with an average return of +1.44% per trade.
3 Months
xxx
Success Rate
8/19 ratings generated profit
42%
Average Return
-8.18%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.11% of your transactions generating a profit, with an average return of -8.18% per trade.
1 Year
Korinne WolfmeyerPiper Sandler
Success Rate
5/19 ratings generated profit
26%
Average Return
-20.50%
reiterated a sell rating 4 months ago
Copying Korinne Wolfmeyer's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -20.50% per trade.
2 Years
xxx
Success Rate
4/19 ratings generated profit
21%
Average Return
-43.46%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 21.05% of your transactions generating a profit, with an average return of -43.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SKIN Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
11
18
14
21
17
Sell
2
2
1
1
0
Strong Sell
0
0
0
0
0
total
13
20
15
22
17
In the current month, SKIN has received 0 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. SKIN average Analyst price target in the past 3 months is 2.00.
Each month's total comprises the sum of three months' worth of ratings.

SKIN Financial Forecast

SKIN Earnings Forecast

Next quarter’s earnings estimate for SKIN is -$0.07 with a range of -$0.10 to -$0.05. The previous quarter’s EPS was $0.16. SKIN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.61% of the time in the same period. In the last calendar year SKIN has Outperformed its overall industry.
Next quarter’s earnings estimate for SKIN is -$0.07 with a range of -$0.10 to -$0.05. The previous quarter’s EPS was $0.16. SKIN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.61% of the time in the same period. In the last calendar year SKIN has Outperformed its overall industry.

SKIN Sales Forecast

Next quarter’s sales forecast for SKIN is $68.45M with a range of $66.00M to $69.86M. The previous quarter’s sales results were $78.19M. SKIN beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 53.19% of the time in the same period. In the last calendar year SKIN has Outperformed its overall industry.
Next quarter’s sales forecast for SKIN is $68.45M with a range of $66.00M to $69.86M. The previous quarter’s sales results were $78.19M. SKIN beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 53.19% of the time in the same period. In the last calendar year SKIN has Outperformed its overall industry.

SKIN Stock Forecast FAQ

What is SKIN’s average 12-month price target, according to analysts?
Based on analyst ratings, Beauty Health’s 12-month average price target is 2.00.
    What is SKIN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for SKIN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is SKIN a Buy, Sell or Hold?
        Beauty Health has a consensus rating of Hold which is based on 0 buy ratings, 5 hold ratings and 0 sell ratings.
          What is Beauty Health’s price target?
          The average price target for Beauty Health is 2.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $2.50 ,the lowest forecast is $1.50. The average price target represents -3.38% Decrease from the current price of $2.07.
            What do analysts say about Beauty Health?
            Beauty Health’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
              How can I buy shares of SKIN?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis